Category: Side Effect: Infections (necrotizing fasciitis, sepsis)
-
Fournier’s Gangrene Is A Side Effect Of Farxiga, Invokana, Jardiance, And Other SGLT2 Inhibitor Diabetes Drugs — Or Is It?
At The Recent American Diabetes Association (ADA) Scientific Sessions There Was An Expression Of Doubt About Warnings For This Association (Posted by Tom Lamb at DrugInjuryWatch.com) In August 2018 the FDA required…
-
FDA: More Reports Of Diabetes Drugs Invokana, Jardiance, And Farxiga Being Associated With Fournier’s Gangrene
Serious Infection In The Genital Area Seems to Be A Drug Class Side Effect Of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Posted by Tom Lamb at DrugInjuryWatch.com) A new FDA analysis article published in…
-
Summer 2016 Drug Injury Lawsuits Report: Diabetes Medicines, Erectile Dysfunction Pills, And Heartburn Medications
Current Product Liability Litigation Cases Involving Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention (Posted by Tom Lamb at DrugInjuryWatch.com) This article will feature three types of…
-
Invokana / Farxiga / Jardiance: Urinary Tract Infections Leading To Urosepsis And Pyelonephritis Are Lesser Known Side Effects
To Date, More Attention Paid To The Association Between These Sodium-Glucose Cotransporter-2 Inhibitors And Diabetic Ketoacidosis Or Acute Kidney Injury (Posted by Tom Lamb at DrugInjuryWatch.com) Over the past year the FDA…
-
Various Drug Safety Issues Continue To Be Associated With Novartis Multiple Sclerosis (MS) Medication Gilenya
ISMP QuarterWatch Report From 2014 States Adverse Events Reports Show That Gilenya Cardiac Risks "were neither rare nor hypothetical" (Posted by Tom Lamb at DrugInjuryWatch.com)The safety profile for the Novartis drug Gilenya (fingolimod) has been controversial for…
-
April 2009 Update: Another Tysabri Patient Develops Serious Brain Infection PML
What Is Progressive Multifocal Leukoencephalopathy (PML), What Causes It, Why Is Tysabri Still On The Market? (Posted by Tom Lamb at DrugInjuryWatch.com) On April 17, 2009 we learned that another multiple-sclerosis patient using the…
-
FDA Warns About Rare Brain Infection PML Linked To Psoriasis Drug Raptiva
European Union Regulators, On Same Day, Recommend That Raptiva Be Withdrawn Because Its Risks Outweigh The Benefits ******************** Update: April 2009: Raptiva Recall In U.S. On April 8, 2009 we learned that Raptiva has been recalled due…
-
FDA Staff Wants Amgen To Add Stronger Warning About Enbrel Side Effects In Children
June 2008 Staff Report Cites Cancers, Infections, And Neurological Problems Similar To Serious Side Effects In Adults (Posted by Tom Lamb at DrugInjuryWatch.com) On June 16, 2008 the FDA released a staff report, "Enbrel…
-
New Study Suggests Tysabri Not Likely Come Back On Market
FDA Will Determine Whether Risks Outweigh Any Potential Benefit Serious side effects associated with Tysabri may outweigh any potential benefit, according to a study published in early November 2005, such that the once-promising drug…